Richard Hammel, PhD
Leader in International Pharmaceutical Business Development
Feb. 12, 2013
7-135 Weaver-Densford Hall, Twin Cities campus
(simulcast to 163/165 LSci, Duluth campus)
RSVP to email@example.com
Richard Hammel, PhD, has over 20 years experience in pharmaceutical managed care, sales, marketing and business development. Currently he is a partner of RJH, IBC, a pharmaceutical/biotechnology consulting firm which provides a broad range of business, financial and product development services. The company has offices in the United States, and affiliates in Europe and Japan.
He has also held senior positions at Matrix Pharmaceuticals and Connetics Corporations, where he completed numerous corporate financing, partnering and licensing agreements. While working at Glaxo Inc., he became one of the innovators of business development and corporate partnering activities. Under his leadership, the company invested in the NEA seed venture capital fund and concluded four corporate partnerships. He has also acted as a consultant with Marketing Corporation of America, providing services for Bristol Myers Squibb, Johnson & Johnson and Warner Lambert.
Hammel received a PhD in pharmacy administration, a master’s of science in hospital pharmacy, and a bachelor of science in pharmacy from the University of Minnesota College of Pharmacy.